Granulocyte-Colony Stimulating Factor Reactivates Human Cytomegalovirus in a Latently Infected Humanized Mouse Model

被引:101
作者
Smith, M. Shane [1 ]
Goldman, Devorah C. [2 ]
Bailey, Alexis S. [2 ]
Pfaffle, Dana L. [2 ]
Kreklywich, Craig N. [3 ]
Spencer, Doran B. [4 ]
Othieno, Florence A. [5 ]
Streblow, Daniel N. [1 ]
Garcia, J. Victor [5 ]
Fleming, William H. [2 ]
Nelson, Jay A. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA
[2] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97239 USA
[3] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97239 USA
[4] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA
[5] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC 27514 USA
基金
美国国家卫生研究院;
关键词
STEM-CELL TRANSPLANTATION; HEMATOPOIETIC PROGENITOR CELLS; HUMAN RETINAL TISSUE; VERSUS-HOST-DISEASE; BONE-MARROW; PERIPHERAL-BLOOD; ALLOGENEIC TRANSPLANTATION; CD34(+) CELLS; IN-VIVO; G-CSF;
D O I
10.1016/j.chom.2010.08.001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human cytomegalovirus (HCMV) is a significant cause of morbidity and mortality in organ transplant recipients. The use of granulocyte-colony stimulating factor (G-CSF)-mobilized stem cells from HCMV seropositive donors is suggested to double the risk of late-onset HCMV disease and chronic graft-versus-host disease in recipients when compared to conventional bone marrow transplantation with HCMV seropositive donors, although the etiology of the increased risk is unknown. To understand mechanisms of HCMV transmission in patients receiving G-CSF-mobilized blood products, we generated a NOD-scid IL2R gamma(null)(c)-humanized mouse model in which HCMV establishes latent infection in human hematopoietic cells. In this model, G-CSF induces the reactivation of latent HCMV in monocytes/macrophages that have migrated into organ tissues. In addition to establishing a humanized mouse model for systemic and latent HCMV infection, these results suggest that the use of G-CSF mobilized blood products from seropositive donors pose an elevated risk for HCMV transmission to recipients.
引用
收藏
页码:284 / 291
页数:8
相关论文
共 34 条
[1]   The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood [J].
Aiuti, A ;
Webb, IJ ;
Bleul, C ;
Springer, T ;
GutierrezRamos, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :111-120
[2]   A comparison of related donor peripheral blood and bone marrow transplants: Importance of late-onset chronic graft-versus-host disease and infections [J].
Anderson, D ;
DeFor, T ;
Burns, L ;
McGlave, P ;
Miller, J ;
Wagner, J ;
Weisdorf, D .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (01) :52-59
[3]   Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation [J].
Asano-Mori, Yuki ;
Kanda, Yoshinobu ;
Oshima, Kumi ;
Kako, Shinichi ;
Shinohara, Akihito ;
Nakasone, Hideki ;
Sato, Hiroyuki ;
Watanabe, Takuro ;
Hosoya, Noriko ;
Izutsu, Koji ;
Asai, Takashi ;
Hangaishi, Akira ;
Motokura, Toru ;
Chiba, Shigeru ;
Kurokawa, Mineo .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 87 (03) :310-318
[4]   Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV [J].
Bentz, Gretchen L. ;
Jarquin-Pardo, Marta ;
Chan, Gary ;
Smith, M. Shane ;
Sinzger, Christian ;
Yurochko, Andrew D. .
JOURNAL OF VIROLOGY, 2006, 80 (23) :11539-11555
[5]   Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue [J].
Bidanset, DJ ;
Rybak, RJ ;
Hartline, CB ;
Kern, ER .
ANTIVIRAL RESEARCH, 2004, 63 (01) :61-64
[6]   Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissue [J].
Bidanset, DJ ;
Rybak, RJ ;
Hartline, CB ;
Kern, ER .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (02) :192-195
[7]   Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle [J].
Blaise, D ;
Kuentz, M ;
Fortanier, C ;
Bourhis, JH ;
Milpied, N ;
Sutton, L ;
Jouet, JP ;
Attal, M ;
Bordigoni, P ;
Cahn, JY ;
Boiron, JM ;
Schuller, MP ;
Moatti, JP ;
Michalle, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :537-546
[8]   Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist [J].
Broxmeyer, HE ;
Orschell, CM ;
Clapp, DW ;
Hangoc, G ;
Cooper, S ;
Plett, PA ;
Liles, WC ;
Li, XX ;
Graham-Evans, B ;
Campbell, TB ;
Calandra, G ;
Bridger, G ;
Dale, DC ;
Srour, EF .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08) :1307-1318
[9]   Cytomegalovirus infection after bone marrow transplantation in children [J].
Castagnola, E ;
Cappelli, B ;
Erba, D ;
Rabagliati, A ;
Lanino, E ;
Dini, G .
HUMAN IMMUNOLOGY, 2004, 65 (05) :416-422
[10]  
Champlin RE, 2000, BLOOD, V95, P3702